MedTrace Logo

A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa®

NCT01096329 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2011-06-08

No results posted yet for this study

Summary

The purpose of this study is to determine if the absorption of the testosterone spray is the same as the Intrinsa® Patch.

Conditions

  • Hypoactive Sexual Desire Disorder

Interventions

DRUG

Testosterone Spray 5% and 1%

Testosterone Spray 5% 2x90uL for 14 days Testosterone Spray 1% 2x90uL for 14 days

DRUG

Intrinsa® Patch and Testosterone Spray 5%

Testosterone Spray 5% 2x90uL for 14 days Intrinsa® Patch for 14 days

DRUG

Intrinsa® Patch and Testosterone Spray 1%

Testosterone Spray 1% 2x90uL for 14 days Intrinsa® Patch for 14 days

Sponsors & Collaborators

  • VIVUS LLC

    lead INDUSTRY

Principal Investigators

  • Mark Allison, MD · MDS Pharma Services Inc

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01096329 on ClinicalTrials.gov